1978 1980 1981 1982 1983 1984

1985 1986 1987 1988 1989 1990

1992 1993 1994 1995 1996 1997

1998 1999 2000 2001 2002 2003

2004 2005 2006 2007 2008

Prediction of extraprostatic extension of prostate cancer based on needle biopsy findings: perineural invasion lacks significance on multivariate analysis.
Egan AJ, Bostwick DG.

Atypical small acinar proliferation suspicious for malignancy in prostate needle biopsies: clinical significance in 33 cases.
Iczkowski KA, MacLennan GT, Bostwick DG.

The focus of "atypical glands, suspicious for malignancy" in prostatic needle biopsy specimens: incidence, histologic features, and clinical follow-up of cases diagnosed in a community practice.
Cheville JC, Reznicek MJ, Bostwick DG.

Anatomic site-specific positive margins in organ-confined prostate cancer and its impact on outcome after radical prostatectomy.
Blute ML, Bostwick DG, Bergstralh EJ, Slezak JM, Martin SK, Amling CL, Zincke H.

Low-grade collecting duct carcinoma of the kidney: report of 13 cases of low-grade mucinous tubulocystic renal carcinoma of possible collecting duct origin.
MacLennan GT, Farrow GM, Bostwick DG.

Detection of chromosomal anomalies and c-myc gene amplification in the cribriform pattern of prostatic intraepithelial neoplasia and carcinoma by fluorescence in situ hybridization.
Qian J, Jenkins RB, Bostwick DG.

Malignant lymphoma of the bladder: evidence from 36 cases that low-grade lymphoma of the MALT-type is the most common primary bladder lymphoma.
Kempton CL, Kurtin PJ, Inwards DJ, Wollan P, Bostwick DG.

Classification of renal cell carcinoma: Workgroup No. 1. Union Internationale Contre le Cancer (UICC) and the American Joint Committee on Cancer (AJCC).
Storkel S, Eble JN, Adlakha K, Amin M, Blute ML, Bostwick DG, Darson M, Delahunt B, Iczkowski K.

Evaluating prostate needle biopsy: therapeutic and prognostic importance.
Bostwick DG.

Intestinal metaplasia is not a strong risk factor for bladder cancer: study of 53 cases with long-term follow-up.
Corica FA, Husmann DA, Churchill BM, Young RH, Pacelli A, Lopez-Beltran A, Bostwick DG.

Clinical significance of high-grade prostatic intraepithelial neoplasia in transurethral resection specimens.
Pacelli A, Bostwick DG.

Ultrastructure of prostatic intraepithelial neoplasia.
Bostwick DG, Pacelli A, Lopez-Beltran A.

Neurofilament heavy chain-like messenger RNA and protein are present in benign prostate and down-regulated in prostatic carcinoma.
Schleicher RL, Hunter SB, Zhang M, Zheng M, Tan W, Bandea CI, Fallon MT, Bostwick DG, Varma VA.

Identification of a novel transcript up-regulated in a clinically aggressive prostate carcinoma.
Chuaqui RF, Englert CR, Strup SE, Vocke CD, Zhuang Z, Duray PH, Bostwick DG, Linehan WM, Liotta LA, Emmert-Buck MR.

Prostatic adenocarcinoma with atrophic features: malignancy mimicking a benign process.
Egan AJ, Lopez-Beltran A, Bostwick DG.

Simultaneous chromosome 7 and 17 gain and sex chromosome loss provide evidence that renal metanephric adenoma is related to papillary renal cell carcinoma.
Brown JA, Anderl KL, Borell TJ, Qian J, Bostwick DG, Jenkins RB.

A novel human prostate-specific, androgen-regulated homeobox gene (NKX3.1) that maps to 8p21, a region frequently deleted in prostate cancer.
He WW, Sciavolino PJ, Wing J, Augustus M, Hudson P, Meissner PS, Curtis RT, Shell BK, Bostwick DG, Tindall DJ, Gelmann EP, Abate-Shen C, Carter KC.

Human glandular kallikrein 2 (hK2) expression in prostatic intraepithelial neoplasia and adenocarcinoma: a novel prostate cancer marker.
Darson MF, Pacelli A, Roche P, Rittenhouse HG, Wolfert RL, Young CY, Klee GG, Tindall DJ, Bostwick DG.

A review of clinical and pathological prostatitis syndromes.
Roberts RO, Lieber MM, Bostwick DG, Jacobsen SJ.

An enhanced prognostic system for clinically localized carcinoma of the prostate.
Pisansky TM, Kahn MJ, Bostwick DG.

Androgen deprivation as a strategy for prostate cancer chemoprevention.
Aquilina JW, Lipsky JJ, Bostwick DG.

The canine prostate is a spontaneous model of intraepithelial neoplasia and prostate cancer progression.
Waters DJ, Bostwick DG.

High-power (60-watt) potassium-titanyl-phosphate laser vaporization prostatectomy in living canines and in human and canine cadavers.
Kuntzman RS, Malek RS, Barrett DM, Bostwick DG.

Prostate cancer masquerading as a zygomatic posttraumatic mass.
Harlan JW, Petty PM, Bostwick DG.

Stability of the glycoprotein A-80 in prostatic carcinoma subsequent to androgen deprivation therapy.
Gould VE, Doljanskaia V, Gooch GT, Bostwick DG.

Artificial neural networks improve the accuracy of cancer survival prediction.
Burke HB, Goodman PH, Rosen DB, Henson DE, Weinstein JN, Harrell FE Jr, Marks JR, Winchester DP, Bostwick DG.

Prostatic intraepithelial neoplasia in dogs with spontaneous prostate cancer.
Waters DJ, Hayden DW, Bell FW, Klausner JS, Qian J, Bostwick DG.

The extent and multicentricity of high-grade prostatic intraepithelial neoplasia in clinically localized prostatic adenocarcinoma.
Qian J, Wollan P, Bostwick DG.

Detection of c-myc oncogene amplification and chromosomal anomalies in metastatic prostatic carcinoma by fluorescence in situ hybridization.
Jenkins RB, Qian J, Lieber MM, Bostwick DG.

Prostatic intraepithelial neoplasia occurs spontaneously in the canine prostate.
Waters DJ, Bostwick DG.

A multiple prognostic index predictive of disease outcome after irradiation for clinically localized prostate carcinoma.
Pisansky TM, Kahn MJ, Rasp GM, Cha SS, Haddock MG, Bostwick DG.

Staging prostate cancer--1997: current methods and limitations.
Bostwick DG.

Prostate pathology case study seminar.
Montironi R, Alexander E, Bostwick DG.

Evaluating radical prostatectomy specimens: therapeutic and prognostic importance.
Bostwick DG, Montironi R.